Research on depression and its treatment. Covers stress-response biology, ketamine and dopamine-targeting therapies, treatment-resistant cases, and brain mechanisms.
A new study found that a one-hour inhalation session with 25% nitrous oxide gas improved depression symptoms for over two weeks, with fewer adverse side effects compared to higher concentrations. The effects were nearly as effective as 50% nitrous oxide at rapidly relieving symptoms of treatment-resistant depression.
A single treatment involving breathing in a mixture of oxygen and nitrous oxide significantly improved symptoms in people with treatment-resistant depression. Symptoms of depression improved rapidly following treatment, with benefits lasting for several weeks.
A phase 2 trial found that a single one-hour treatment with nitrous oxide can relieve symptoms of treatment-resistant depression for several weeks. The study showed significant improvements in depression symptoms, with a four-fold lower risk of adverse effects at lower concentrations.
Researchers found a novel biomarker indicating resilience to chronic stress in the brain, which is largely absent in people suffering from major depressive disorder. This absence is associated with pessimism in daily life and reduced adaptive responses to stress.
Research reveals a strong link between hyperhomocysteinemia and migraine with aura in rats, showing elevated HCY levels increase susceptibility to cortical spreading depression. The study suggests timely correction of high homocysteine levels may be beneficial for treating migraine-related symptoms.
A systematic review of treatments for depression in people with coronary heart disease suggests that exercise is the most effective short-term treatment. The study also found that combination treatments, including antidepressants and psychotherapy, had stronger effects than other interventions.
A recent study used cell phone apps, wearables, brain activity, and lifestyle factors to generate individualized predictions of depression. The results could lead to tailored treatment plans for mental health, moving beyond one-size-fits-all approaches.
Researchers have developed a deep-learning model that can track changes in speech coordination features to detect depression. The app aims to provide early intervention before severe depression sets in, potentially saving lives.
A new study published in Molecular Psychiatry found that people whose sleep pattern goes against their natural body clock are more likely to have depression and lower levels of wellbeing. Being genetically programmed to be an early riser is protective against major depression, and improves wellbeing.
Postpartum women in bad romantic relationships are more likely to suffer symptoms of depression and have lower heart rate variability (HRV), which can impact long-term wellness and mortality. Research shows a clear link between relationship quality during pregnancy and postpartum depression and HRV.
A new meta-analysis of 215 COVID-19 studies reveals a wide range of ways the virus affects mental health and brain function. Common symptoms include fatigue, loss of smell, depression, anxiety, and headaches, even in mild cases, suggesting that mental health impacts may be more prevalent than expected.
During the COVID-19 pandemic, many ECT centers reduced services, but most were able to react and return to care by mid-summer. The survey found that 70% of sites had patients return to inpatient psychiatric care due to unscheduled ECT cancellations.
A large genetic study suggests that going to bed earlier may be associated with a lower risk of major depression. The study found that one-hour earlier sleep timing corresponded to a 23% lower likelihood of having a major depressive disorder. Further research is needed to understand the mechanisms behind this effect and how shifting sl...
A large-scale genetic analysis of depression identified 178 loci and 223 single-nucleotide polymorphisms associated with increased depression risk. The study, involving over 1.2 million participants, provides new insights into the biological basis of depression and potential drug repurposing.
Researchers from Synapsy have identified lactate's key features, including NADH and neurogenesis, which contribute to its antidepressant effect. Lactate restores adult neurogenesis in the hippocampus, a region crucial for memory and depression.
A new study has identified 178 gene variants linked to major depression, providing insights into the disorder's genetic complexity and potential treatments. The findings may help identify individuals most at risk of depression and inform personalized treatment approaches.
Researchers from iPSYCH have identified 33 new genetic variants associated with bipolar disorder, more than doubling the number of known genetic risk factors. These variants play a role in brain functions and signalling between nerve cells, providing potential ideas for new treatments.
A study published in BJPsych Open found that women with depression during pregnancy or a history of depression had reduced quality of mother-infant interactions. Despite this, all mothers and their babies improved over time, indicating potential for future attunement.
A new study from Rice University found that widowed spouses with higher levels of bodily inflammation experienced more severe symptoms of depression three months later. The researchers identified a potential biomarker to predict who is at greatest risk for long-term repercussions of loss.
A NYITCOM researcher has secured a $1.6 million NIH grant to study the role of brain cells called astrocytes in regulating dopamine signaling. The study aims to identify new therapeutic treatments for clinical depression, which affects over 260 million people worldwide.
A network meta-analysis of 58 randomized controlled trials involving 9,301 patients found that psychotherapy and pharmacotherapy were significantly more effective than care-as-usual or waitlist control. Combined treatment, particularly cognitive behavioral therapy, was better than either treatment alone.
A new study found that almost half of women with babies under six months old met the threshold for postnatal depression during the first COVID-19 lockdown. Social isolation and lack of support were significant contributors to this increased risk.
After cognitive behavioral therapy, serotonin transporter levels increased in individuals recovering from depression. This finding suggests that the serotonin system may play a role in protecting against depression, rather than causing it.
Researchers found a significant association between COVID-19-related income loss and financial strain with depressive symptoms, independent of anxiety. Participants who experienced a decrease in income over the study period reported an increase in depressive symptoms.
A study by the University of Ottawa found nearly two-thirds of Black individuals in Canada suffer from severe depressive symptoms. Women are disproportionately affected, with those who experience racial discrimination also showing higher rates.
A new neuroimaging technique using diffuse optical tomography studied brain stimulation for depression, finding reduced brain activation in response to rTMS. The study suggests that treatment parameters may need adjusting for patients with severe depression.
Patients with implantable cardioverter defibrillators (ICDs) are at risk of developing anxiety and depression after implantation, according to a new study. Regular screening is necessary to identify patients who may benefit from additional support.
A study by University of Surrey found that frequent internet use among older adults (55-75) was beneficial for mental health and quality of life under lockdown. Those who used the internet more frequently, particularly for communication, had lower depression scores and an enhanced quality of life.
Researchers at UZH found that increased sensitivity in a specific brain region contributes to anxiety and depression in response to stress. The study establishes an objective neurobiological measure for stress resilience in humans, which may aid in selecting professions or developing stress resilience training.
In a small study, psilocybin, the active compound in magic mushrooms, was found to be at least as effective as a leading antidepressant medication in reducing depressive symptoms. The results showed that depression scores decreased more quickly and were greater in magnitude in the psilocybin group compared to the escitalopram group.
Researchers have identified 19 genes and 25 corresponding proteins that may contribute to the cause of depression. These findings offer promise as potential targets for new depression treatments and could serve as biomarkers for depressive symptoms.
A study of over 42,000 children found that mothers who took antidepressants during pregnancy were more likely to have children with affective disorders, but not due to the medication itself. The research suggests that parental mental illness may be the underlying cause.
A study found that cells from people with major depressive disorder (MDD) have accelerated DNA methylation clocks, indicating an increased risk of mortality. The researchers discovered that these changes persisted even after accounting for lifestyle factors, suggesting a potential biological mechanism underlying the condition.
A new study by UMass Amherst researchers found that couples where one partner is responsive and supportive can maintain better relationship quality despite the other's depression or external stress. The study involved over 200 newlywed couples and found that responsiveness was associated with improved relationship outcomes.
A new study from Aarhus University shows that eight weeks of training in compassion can significantly improve the well-being of relatives. The training helps them deal with difficult emotions and life events, reducing symptoms of depression, anxiety, and stress.
Cells from depressed individuals have higher rates of methylation at specific DNA sites, accelerating their cellular age by approximately two years compared to healthy controls. This accelerated aging is linked to increased mortality risk, as measured by the GrimAge clock.
A recent study by Syracuse University researchers found that EMS workers are three times more likely to experience mental health issues such as depression and posttraumatic stress disorder. Daily mental health symptoms can be reduced through recovery activities like exercising, socializing, and finding meaning in challenges.
A small study found that exposure to phthalates and bisphenols, commonly found in plastics, may contribute to lower progesterone levels during pregnancy and an increased likelihood of developing postpartum depression. Reducing exposure to these chemicals could be a potential avenue for preventing postpartum depression.
Researchers at the University of Helsinki found that depression alters the way the brain processes visual information, with depressed individuals perceiving contrast as stronger. The study used two visual tests to compare brain function in patients with depression to those without.
Researchers identified a novel neural circuit that mediates the reciprocal control of feeding and psychological states in mouse models. Correcting this circuit eliminated anxiety, depression, and reduced body weight in obese mice.
A new study by Anglia Ruskin University found that women with sensory loss are more than twice as likely to report depression and anxiety as men. Women with dual sensory impairment were almost three and a half times more likely to experience depression.
Research suggests non-drug therapies like exercise and social interactions may reduce symptoms of depression in people with dementia. These interventions are found to be as or more effective than drugs in treating depression, suggesting a shift towards 'social' prescribing.
A multinational study of nearly 200,000 people found significant sex-dependent differences in the genetics of schizophrenia, bipolar disorder, and major depressive disorders. The findings suggest that interactions between genes and sex may affect disease risk and progression.
A study analyzing metaphors used by people with severe depression in blogs reveals the importance of social factors, surroundings, and medical practice. The research also highlights the usefulness of blogs as an outlet for expressing and understanding depression experiences.
A study by Thomas Jefferson University found that 87% of incoming medical students reported imposter syndrome, a mental health challenge linked to depression, anxiety, and self-sabotage. The researchers suggest that supportive feedback, collaborative learning, and individual counseling can help alleviate imposter syndrome.
A meta-analysis of over 53,000 patients found no evidence that beta blockers increase the risk of depression or most other psychiatric symptoms. However, sleep disturbance was linked to treatment with beta blockers.
A systematic review of 65 studies reveals that 1 in 5 healthcare workers experienced depression, anxiety, and/or PTSD during the pandemic. The highest pooled rates were found in Middle East countries.
A six-week training program improved emotional resilience in veterans by increasing confidence in regulating emotions and reducing symptoms of anxiety and depression. Brain function changes also occurred, with reduced crosstalk between brain regions involved in emotional processing.
Researchers have identified ezogabine, a drug that opens potassium channels in the brain, as a promising new approach to treating depression. The study showed significant improvements in depressive symptoms and anhedonia in patients with depression.
A new Northwestern University study finds that trained paraprofessionals delivering cognitive-behavioral therapy can reduce depressive symptoms in pregnant women as effectively as mental health professionals. This approach may help address the growing need for treatment and alleviate the burden on overwhelmed healthcare providers.
A new study found that people with depression and anxiety may experience dementia symptoms about two years earlier than those without these conditions. Those with bipolar disorder or schizophrenia may start experiencing symptoms three to seven years earlier.
Research suggests that cognitive behavioral therapy (CBT) can help unemployed individuals find a new job or transition to full-time work within 16 weeks. The treatment also improves productivity and reduces negative beliefs associated with depression.
Researchers found that training primary care physicians in depression recognition and medication treatment can prevent suicide, often halving the risk. Reducing access to lethal methods, such as firearms, is also crucial in preventing suicidal behavior.
A study of over 2,100 first-year medical residents found that irregular sleep schedules can increase the risk of depression and negative mood. Those with variable wake-up times and sleep times were more likely to experience symptoms of depression.
A study by University of Granada researchers reveals that psychological variables contributed to increased anxiety and depression among pregnant women during the COVID-19 pandemic. Women who gave birth during the pandemic reported greater stress in delivery processes and lower quality of care received.
A study of over 7,100 veterans found that those with a combination of high depression, low social support, and low psychological resilience reported poor well-being. Higher psychological resilience mitigated the impact of depression on well-being.
The study analyzed tweets of 186 users taking antidepressant medication, revealing increased activity and positive emotions during treatment. Users posted longer messages with more interactions and fewer messages at night.
Researchers discover that a small group of neurons in the brain play a crucial role in depression. Chronic stress alters their function, leading to depressive behavior. Stimulation of these neurons reverses symptoms, suggesting a promising new approach to treating depression.
A study led by Johns Hopkins Bloomberg School of Public Health finds that nearly 60% of low-income, middle-aged African-American women with uncontrolled hypertension screened positive for depression. The researchers emphasize the need for routine screening and treatment for these women.
Long-COVID symptoms persist for over 12 weeks in many patients, causing health problems like cough, fatigue, and cognitive difficulties. Researchers explore potential pathways and propose strategies to manage symptoms using insights from studies of chronic fatigue syndrome, fibromyalgia, and depression.